<h3>Gainers</h3>
<ul>
<li>Tandem Diabetes Care (NASDAQ:TNDM) stock increased by 35.0% to $25.0 during Friday's regular session. The market value of their outstanding shares is at $1.2 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 22.21% to $0.11. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 19.64% to $2.68. The market value of their outstanding shares is at $4.0 million. </li>
<li>enVVeno Medical (NASDAQ:NVNO) shares increased by 18.11% to $11.8. The market value of their outstanding shares is at $6.5 million. </li>
<li>Nasus Pharma (AMEX:NSRX) shares moved upwards by 18.0% to $5.9. The company's market cap stands at $58.7 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:SNSE) stock increased by 16.86% to $31.81. The company's market cap stands at $34.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>GRAIL (NASDAQ:GRAL) stock fell 47.8% to $53.02 during Friday's regular session. The market value of their outstanding shares is at $3.9 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Dermata Therapeutics (NASDAQ:DRMA) shares decreased by 25.86% to $1.43. The company's market cap stands at $5.4 million. </li>
<li>BioRestorative Therapies (NASDAQ:BRTX) shares declined by 15.75% to $0.23. The market value of their outstanding shares is at $6.2 million. </li>
<li>Candel Therapeutics (NASDAQ:CADL) shares declined by 14.54% to $5.08. The market value of their outstanding shares is at $326.6 million. </li>
<li>Harmony Biosciences Hldgs (NASDAQ:HRMY) shares fell 13.67% to $29.69. The company's market cap stands at $1.9 billion. </li>
<li>Regencell Bioscience (NASDAQ:RGC) shares decreased by 12.3% to $29.34. The company's market cap stands at $16.5 billion. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARKG

In Friday's trading session, Tandem Diabetes Care (TNDM) saw a significant gain of 35% to $25, following its Q4 earnings report, while Bristol-Myers Squibb's Celgene CVR (CELGR) rose 22.21% to $0.11. Other notable gainers included Cardio Diagnostics (CDIO) up 19.64%, enVVeno Medical (NVNO) up 18.11%, and Nasus Pharma (NSRX) up 18%. Conversely, GRAIL (GRAL) experienced a sharp decline of 47.8% to $53.02, with Dermata Therapeutics (DRMA) down 25.86%, and BioRestorative Therapies (BRTX) down 15.75%.

benzinga_article

iShares US Medical Devices

Ark Genomic Revolution ETF

ProShares Ultra Health Care ETF

Health Care Select Sector SPDR

SPDR S&P Biotech

ALPS Medical Breakthrough

VanEck Biotech ETF

CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (10/25/2027) TO PUR COM

iShares US Pharma

VG Health

Nasus Pharma

Cardio Diagnostics

Invesco Nasdaq Biotechnology ETF

Bristol-Myers Squibb Company

Direxion Pharma & Medical Bull 3X

Invesco Biotechnology & Genome ETF

iShares Global Healthcare

iShares Genomics Immunology and Healthcare ETF

iShares US Healthcare Providers

enVVeno Medical

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

SPDR S&P Health Equip

First Trust NYSE Arca Biotech Index Fd

Bristol Myers Squibb

Tandem Diabetes

12 Health Care Stocks Moving In Friday's Intraday Session